ATE424410T1 - Interleukin-19. - Google Patents

Interleukin-19.

Info

Publication number
ATE424410T1
ATE424410T1 AT96932967T AT96932967T ATE424410T1 AT E424410 T1 ATE424410 T1 AT E424410T1 AT 96932967 T AT96932967 T AT 96932967T AT 96932967 T AT96932967 T AT 96932967T AT E424410 T1 ATE424410 T1 AT E424410T1
Authority
AT
Austria
Prior art keywords
interleukin
polypeptides
vectors
nucleic acid
producing
Prior art date
Application number
AT96932967T
Other languages
English (en)
Inventor
Craig Rosen
Joseph Kenny
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of ATE424410T1 publication Critical patent/ATE424410T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96932967T 1996-08-30 1996-08-30 Interleukin-19. ATE424410T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/014355 WO1998008870A1 (en) 1996-08-30 1996-08-30 Interleukin-19

Publications (1)

Publication Number Publication Date
ATE424410T1 true ATE424410T1 (de) 2009-03-15

Family

ID=22255746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96932967T ATE424410T1 (de) 1996-08-30 1996-08-30 Interleukin-19.

Country Status (10)

Country Link
EP (2) EP2065396A1 (de)
JP (1) JP2001500369A (de)
AT (1) ATE424410T1 (de)
AU (1) AU7155296A (de)
CA (1) CA2264548A1 (de)
DE (1) DE69637856D1 (de)
DK (1) DK0963377T3 (de)
ES (1) ES2322877T3 (de)
PT (1) PT963377E (de)
WO (1) WO1998008870A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
BR9814904A (pt) * 1997-11-26 2000-10-03 Zymogenetics Inc Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo.
CA2374341A1 (en) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Novel polypeptide
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
PT1531843E (pt) 2001-12-17 2011-10-27 Zymogenetics Inc Método para tratar o cancro cervical
IL164218A0 (en) * 2002-04-11 2005-12-18 Zymogenetics Inc Use of interleukin-19 to treat ovarian cancer
EP2143733A1 (de) 2003-11-21 2010-01-13 ZymoGenetics, Inc. Anti-il-20-Rezeptor-Antikörper und Bindungspartner und Verfahren zur Anwendung bei Entzündungen
MXPA06006377A (es) * 2003-12-03 2006-08-23 Schering Corp Metodos para modular la actividad de citocina y reactivos relacionados.
ES2397241T3 (es) 2004-01-21 2013-03-05 Novo Nordisk Health Care Ag Conjugación de péptidos mediante transglutaminasa
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0702446D0 (en) 2007-02-08 2007-03-21 Sterix Ltd Composition
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
EP3216462A3 (de) 2010-02-26 2017-12-20 Novo Nordisk A/S Stabile, antikörperhaltige zusammensetzungen
CA2800188A1 (en) 2010-05-28 2011-12-01 Novo Nordisk A/S Stable multi-dose compositions comprising an antibody and a preservative
CN111647081B (zh) * 2020-04-28 2022-06-03 武汉百杰康生物科技有限公司 一种重组小鼠抗人白介素19单克隆抗体、制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361549A (en) 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4381295A (en) 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4433092A (en) 1981-03-09 1984-02-21 Champion Spark Plug Company Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
WO1986000991A1 (en) 1984-07-24 1986-02-13 Commonwealth Serum Laboratories Commission Method for determining mimotopes
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
WO1987001130A1 (en) 1985-08-15 1987-02-26 Stauffer Chemical Company Tryptophan producing microorganism
LU86128A1 (fr) 1985-10-18 1987-06-02 Vander Poorten Henri Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
EP0394827A1 (de) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide
EP0464533B1 (de) 1990-06-28 1998-07-29 Hoechst Aktiengesellschaft Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
ES2074879T3 (es) 1991-01-16 1995-09-16 Schering Corp Uso de interleuquina-10 en inmunoterapia adoptiva de cancer.
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures

Also Published As

Publication number Publication date
EP2065396A1 (de) 2009-06-03
EP0963377A4 (de) 2002-08-07
JP2001500369A (ja) 2001-01-16
ES2322877T3 (es) 2009-06-30
PT963377E (pt) 2009-05-11
DE69637856D1 (en) 2009-04-16
EP0963377B1 (de) 2009-03-04
DK0963377T3 (da) 2009-05-18
EP0963377A1 (de) 1999-12-15
AU7155296A (en) 1998-03-19
WO1998008870A1 (en) 1998-03-05
CA2264548A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DK0963377T3 (da) Interleukin-19
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
ATE412740T1 (de) Menschliches alpha-endokin
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
WO1998021343A8 (en) Genes encoding telomerase proteins
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
WO2002046409A3 (en) Proteins and nucleic acids encoding same
DK1082423T3 (da) Cyclin E2-gener og -proteiner
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
WO2002085922A3 (en) Proteins and nucleic acids encoding same
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
DK0708831T4 (da) Celledensitetsforstærkede proteintyrosinphosphataser
PT977859E (pt) O factor neurotrofico nnt-1
WO1998029438A3 (en) Cortistatin polypeptides
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO1996038556A3 (fr) Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse
WO2002081629A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002072770A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU3667397A (en) Recombinant n-proteinase, and the production, methods and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0963377

Country of ref document: EP